These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8269281)

  • 1. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia.
    Urbanski SJ; Edwards DR; Hershfield N; Huchcroft SA; Shaffer E; Sutherland L; Kossakowska AE
    Diagn Mol Pathol; 1993 Jun; 2(2):81-9. PubMed ID: 8269281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
    Onisto M; Garbisa S; Caenazzo C; Freda MP; Di Francesco C; Nitti D; Liotta LA; Stetler-Stevenson WG
    Diagn Mol Pathol; 1993 Jun; 2(2):74-80. PubMed ID: 8269280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
    Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
    Wang M; Fudge K; Rhim JS; Stearns ME
    Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period.
    Das SK; Yano S; Wang J; Edwards DR; Nagase H; Dey SK
    Dev Genet; 1997; 21(1):44-54. PubMed ID: 9291579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
    Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion.
    Khokha R; Denhardt DT
    Invasion Metastasis; 1989; 9(6):391-405. PubMed ID: 2689386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma.
    Shi Y; Parhar RS; Zou M; Hammami MM; Akhtar M; Lum ZP; Farid NR; Al-Sedairy ST; Paterson MC
    Br J Cancer; 1999 Mar; 79(7-8):1234-9. PubMed ID: 10098765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix-degrading metalloproteinases in tumor progression.
    Matrisian LM; Wright J; Newell K; Witty JP
    Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
    Polette M; Clavel C; Birembaut P; De Clerck YA
    Pathol Res Pract; 1993 Nov; 189(9):1052-7. PubMed ID: 8302724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation.
    Waterhouse P; Denhardt DT; Khokha R
    Mol Reprod Dev; 1993 Jul; 35(3):219-26. PubMed ID: 8352925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.